Industry Research by Koncept Analytics
Global Vertigo Market: Industry Analysis & Outlook ----------------------------------------(2017-2021) November 2017
Globa Vertigo Market: Industry Analysis & Outlook (2017-2021)
1
Executive Summary Vertigo is a medical condition where a person feels as if they or the objects around them are moving when they are not. Often it feels like a spinning or swaying movement. This may be associated with nausea, vomiting, sweating, or difficulties walking. It is typically worsened when the head is moved. Vertigo is the most common type of dizziness. The causes for vertigo can be divided into two categories: Peripheral and Central. Peripheral is linked to the inner ear whereas central is linked to problems in Central Nervous System. Peripheral vertigo can be further segmented into five major categories: Benign paroxysmal positional vertigo (BPPV), Acute Unilateral Vestibulopathy, Meniere’s Disease and Vestibular Schwannoma. Amongst all the stated indication, Meniere’s disease represents the largest growth opportunity for the market players with its continuously rising incidence. Growth of global vertigo market is expected to be driven by factors such as rising incidence and prevalence of peripheral etiologies of vertigo, increasing geriatric population, growing healthcare expenditure and improving disposable income. Further, the market growth could be hindered by side effects of currently prescribed medication, the high cost of treatment and tedious drug approval process. The key trends for the market include extensive research & development and different approaches being adopted by drug manufacturers in order to target vertigo. A key drug OTIVIDEX, which is currently in third phase of clinical trials and is being developed by Otonomy Inc., is discussed in the report. The drug is easier to use and provides a higher and sustained concentration of dexamethasone relative to existing injections. Further, it is anticipated to provide a well-accepted treatment option for Meniere’s Disease, if successfully developed. The report “Global Vertigo Market: Industry Analysis & Outlook (2017-2021)” analyzes the development of this market, with focus on Europe and US regions. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The four major players involved in the development of breakthrough drug therapy for vertigo: Auris Medical Holding AG., Sensorion SA, Otonomy, Inc. and Sound Pharmaceuticals, Inc. are being profiled along with their key financials and strategies for growth.
Globa Vertigo Market: Industry Analysis & Outlook (2017-2021)
2
All of the drugs presently available to treat acute vertigo episodes have sedative effects, which impairs central compensation mechanisms and the patient’s ability to function normally while being treated. Companies have realized the need for an effective solution and are spending heavily on research and development of a novel therapy in order to reap the first movers advantage. Global Recurrent Vestibular Vertigo Patient Forecast (2016-2021)
Million
• In 2016, … million people were recorded to be suffering from recurrent vertigo crisis and this patient volume is expected to be recorded at … million in 2021, thereby, growing at a CAGR of …% from 2016 to 2021. • By 2021, the global MD patient volume is forecasted to be recorded at … million, increasing from … million in 2016, depicting an anticipated CAGR of …%, spanning from 2016 to 2021. • In 2016, MD accounted for highest volume share of treatable patients with …% share, followed by BPPV and acute unilateral vestibulopathy with …% and …% shares, respectively. 2016
2017
2018
2019
2020
2021
Global Meniere’s Disease Patient Forecast (2016-2021)
Million
Global Treatable Vertigo Patient by Indication (2016)
Meniere's Disease 2016
2017
2018
2019
2020
2021
BPPV Acute Unilateral Vestibulopathy
Globa Vertigo Market: Industry Analysis & Outlook (2017-2021)
3
The market players indulged in the development of novel therapies to cure vertigo crisis are focusing on different approaches in terms of mechanism of action of drug. Europe Recurrent Vestibular Vertigo Patient Forecast (2016-2021)
Million
• In 2016, the volume of recurrent vertigo patients was noted at … million and is expected to be recorded at … million in 2021, growing at a CAGR of …%, spanning from 2016 to 2021. • The US recurrent vestibular vertigo patient volume was recorded at … million and is expected to reach … million in year 2021. The patient pool is expected to grow at a CAGR of …%. • In Europe, MD accounted for highest share for treatable patient volume with …%, followed by BPPV and acute unilateral vestibuloapathy with …% and …% shares, respectively. 2016
2017
2018
2019
2020
2021 Europe Treatable Vertigo Patient by Indication
Million
The US Recurrent Vestibular Vertigo Patient Forecast (2016-2021)
2016
2017
2018
2019
2020
2021
Meniere's Disease
BPPV
Acute Unilateral Vestibulopathy
Vestibaular Schwannoma
Globa Vertigo Market: Industry Analysis & Outlook (2017-2021)
4
Contact Us:
Disclaimer
This is a licensed product of Koncept Analytics. You cannot reproduce, publish, distribute, publicly display, sell or create other works from this report or use them in any way for commercial purpose without our prior permission. Further, you cannot copy this material, by any means (including electronic copies), for distribution to others unless you have purchased the corporate license of this report. We believe the sources are reliable, but Koncept Analytics does not warranty the accuracy or completeness of the data. The data presented in the report is updated at the publication date but is subject to change at subsequent releases. All possible efforts have been made to ensure accuracy of data. However, investors should not completely rely on the information given in this report and must make decisions based on their own investment strategy, risk management and capital adequacy.
For Report Purchase Click Below: http:// www.konceptanalytics.com/Researchreport/global-vertigo-market-industry-analysis-outlook-2017-2021-27471.aspx Koncept Analytics CS-36, First Floor, Ansal Plaza Vaishali, Ghaziabad, U.P. – 201010 T: +91-120-4130959 M: +91-9871694789 vikas@konceptanalytics.com www.konceptanalytics.com